sign in Biological Technology

Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305

CAMBRIDGE, Massachusetts and LAUSANNE, Switzerland, August 6 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS ), a drug development company focused on developing proprietary targeted medicines for cancer treatment and Debiopharm Group (Debiopharm), a group of companies with a focus on the developme...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

STAMFORD, Conn. and PT. RICHMOND, Calif., Aug. 2 /PRNewswire-FirstCall/ -- Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ) today announced entry into an exclusive license and collaboration agreement to commercialize Intermezzo ((R)) (z...

Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic

LAUSANNE, Switzerland and MEDFORD, Massachussets, July 30 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and MSM Protein Technologies (MSM), a human ...

NPL and University of Surrey sign £10m deal

The National Physical Laboratory (NPL) and the University of Surrey have signed an agreement to collaborate on the delivery of a GBP10m programme to translate the results of research into innovation that makes a real-world difference. The collaboration is supported by a GBP4m Knowledge Transfer Ac...

Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test

LAKE ZURICH, Ill., July 14 /PRNewswire/ -- Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today it has signed a five-year exclusive worldwide agreement with Verax Biomedical Incorporated to market, se...

Synthetic Genomics Inc. and ExxonMobil Research and Engineering Company Sign Exclusive, Multi-Year Agreement to Develop Next Generation Biofuels Using Photosynthetic Algae

LA JOLLA, Calif., July 14 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company applying genomic-driven commercial solutions to address a variety of global challenges including energy and the environment, announced today a multi-year research and development agreement with E...

Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours

LAUSANNE, Switzerland and TAMPA, Florida, June 18 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Moffitt Cancer Center (Moffitt), a non-profit Fl...

Elsevier and NextBio Sign Partnership to Enrich ScienceDirect Content, Accelerating Life Sciences, Health Sciences and Chemistry Research

AMSTERDAM, June 12 /PRNewswire/ -- - Improving Research Discoverability and Productivity Elsevier today announced a new partnership agreement with NextBio, provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked wit...

Immucor and Alverno Clinical Laboratories Sign Five-Year Automation Agreement

NORCROSS, Ga., May 27 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD ), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that it has signed a five-year agreement with Alverno Clinical Laboratories, LLC, one of the largest...

BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management

Alliance Aims to First Develop Powerful Tools for Detecting Ovarian Cancer Earlier FRANKLIN LAKES, N.J. and MALVERN, Pa., May 4 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ) and Fujirebio Diagnostics, Inc., announced today the signing of a worldwide development ...

Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities

Concurrent restructuring of outstanding convertible debentures of Victhom to be completed by way of plan of arrangement QUEBEC, April 30 /PRNewswire-FirstCall/ - Victhom Human Bionics Inc. ("Victhom", TSX: VHB) and Otto Bock HealthCare GmbH ("Otto Bock") announced today the execution on Apr...

Waters and University of Warwick Sign Research Agreement Designed to Foster Adoption of Novel MS Technologies

Centerpiece of the agreement is the establishment of The Waters Centre for BioMedical Mass Spectrometry MILFORD, Mass., April 15 /PRNewswire/ -- Waters Corporation (NYSE: WAT ) and the University of Warwick , Coventry and Warwickshire, England, today signed a collaborative research ag...

ZyGEM Corp. and VWR International Europe BVBA Sign Agreement to Distribute Breakthrough DNA Extraction Technology in Europe

- Extends Successful Existing Distribution Agreement for the Americas - - The Agreement for Europe Will Ensure Researchers Can Easily Access ZyGEM's Growing Line of DNA Extraction Kits - - ZyGEM's Technology Enables Lower-Cost DNA Extraction and Is Ideally Suited to Automation and High-T...

Stemgent, CellDesign Sign Co-Exclusive Marketing Agreement on Stem Cell-Based Adipocyte Research Products

- Stemgent to provide CellDesign's proprietary adipocyte differentiation kits - SAN DIEGO and NEW HAVEN, Conn., March 24 /PRNewswire/ -- Stemgent has signed a co-exclusive license to market CellDesign's AdipoDesign Starter Kit and AdipoDesign MaxiKit, which enable researchers to grow and stud...

AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia

All amounts are in US dollars QUEBEC CITY, March 6 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the signing of a development, commercialization and licensing agreement ...

Immtech and Beijing Pharmaceutical Group Co. Sign Memorandum of Understanding to Explore Developing Strategic Business Alliance

NEW YORK, Feb. 27 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) today announced that the Company has signed a Memorandum of Understanding (MOU) confirming its interest in exploring the development of a strategic alliance with Beijing Pharmaceutical Group Co. L...

Calvert Research and CureDM Sign Collaborative Agreement

Calvert Research signs collaborative agreement with CureDM to continue the preclinical development of CureDM's HIP2B peptide targeted for the treatment of type 1 and 2 diabetes patients. Cary, NC (PRWEB) February 25, 2009 -- Calvert Research, LLC (a Calvert Holdings...

Cumberland Emerging Technologies and UT Research Foundation Sign License Agreement for New Technology

NASHVILLE, Tenn. and KNOXVILLE, Tenn., Feb. 10 /PRNewswire/ -- Nashville-based Cumberland Emerging Technologies, Inc. (CET) and the University of Tennessee Research Foundation (UTRF) today announced they have entered into a license agreement for a promising new asthma treatment discovered at...

DSM and Crucell Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6(R) Cell Line Proteins

LEIDEN, The Netherlands, and PARSIPPANY, N.J., Feb. 10 /PRNewswire/ -- DSM Biologics and Crucell N.V. (Euronext, Nasdaq: CRXL ; Swiss Exchange: CRX) announced today that they have entered into an agreement with Bioceros B.V. of Utrecht, The Netherlands to join their Vendor Network. Under the ter...

Debiopharm and Pharmaleads Sign License Agreement for Debio 0827 or PL37 in Treatment of Chronic Pain Conditions

LAUSANNE, Switzerland and PARIS, February 9 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Pharmaleads SAS, a science driven drug discovery and early development company,...

Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement

GAITHERSBURG, Md. and ATLANTA, Feb 4 /PRNewswire/ -- Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, and Expression Therapeutics, a biotechnology company specializing in factor VIII-based therapeutics, today an...

Air Products and Alter NRG Sign JDA on Renewable Energy Projects

LEHIGH VALLEY, Pa., Feb. 4 /PRNewswire-FirstCall/ -- Air Products (NYSE: APD ) and Alter NRG Corp. (TSX: NRG) today announced the signing of a Joint Development Agreement (JDA) to pursue renewable energy opportunities in North America and Europe. The non-exclusive agreement gives Air Products t...

Novavax and Vivalis Sign a Research License Agreement to Use the EB66(R) Cell Line for the Production of Virus Like Particle Based Vaccines

ROCKVILLE, Md. and NANTES, France, Feb. 4 /PRNewswire-FirstCall/ -- NOVAVAX (Nasdaq: NVAX ) and Vivalis (NYSE Euronext: VLS) announced today the completion of a research license to use the Vivalis proprietary EB66(R) cell line, for the production of Novavax VLP based vaccines. Through this colla...

Progentix Orthobiology and NuVasive Sign Investment Agreement

BILTHOVEN, The Netherlands, January 14 /PRNewswire/ -- Progentix Orthobiology B.V. announced today that it has closed an investment agreement with NuVasive, a medical device company focused on developing products for minimally disruptive surgical treatments for the spine. Under the terms of th...

ASM International N.V. and SAFC Hitech(TM) Sign Certified Manufacturer and Partnership Agreement

Deal Paves Way For Use of ALD Ultra High-k Insulators; Marks Transition to 3x nm Memory Nodes ALMERE, The Netherlands and ST. LOUIS, Jan. 6 /PRNewswire-FirstCall/ -- ASM International N.V. (Nasdaq: ASMI ; Euronext Exchange in Amsterdam: ASM) and SAFC Hitech(TM), a business segment within SA...

bwin and Harvard Medical School Faculty Sign 5-Year Research Cooperation Agreement

VIENNA, Austria, December 15 /PRNewswire-FirstCall/ -- bwin, the world's leading online gaming company, and the Division on Addictions at the Cambridge Health Alliance, a Harvard Medical School Teaching Affiliate, have just signed an agreement for research collaboration for five years. The researc...

Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist

LUGANO, Switzerland, November 27 /PRNewswire/ -- Helsinn Healthcare's Top management today announced that it has signed a partnering agreement with Zealand Pharma, for the development and worldwide commercialization of ZP1846, a GLP-2 (glucagon-like peptide-2) receptor agonist which provides a...

VisualSonics and Seno Medical Instruments Sign Exclusive Opto-Accoustic Licensing Agreement for Preclinical Research

International Agreement Licenses Seno's Opto-Acoustic Imaging Technology To VisualSonics to Enable Molecular Imaging at the Cellular Level and Aid in the Pursuit of Neurology, Regenerative Medicine, Inflammation, and Cancer Applications TORONTO and SAN ANTONIO, TX, Nov. ...

Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway

LAUSANNE, Switzerland and BANGALORE, India, November 20 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Aurigene Discovery Technologies Ltd (Aurigene), a Bangalore-based fully...

Med Discovery and Laborium Biopharma Sign a Bioprocess Development Partnership Agreement

Med Discovery S.A., a Swiss biotech firm and Laborium Biopharma, a subsidiary of Validapro Biosciences Inc. have signed a partnership agreement for the development and optimization of protein bioprocess production and scale-up. Laval, Quebec (PRWEB) November 19, 2008 --...

Azur Pharma and Elan Corporation (NYSE: ELN) Sign Agreement to Develop a Once-Daily Clozapine

DUBLIN, November 10 /PRNewswire/ -- Azur Pharma Limited ("Azur") today announced that it has entered into an agreement to develop and commercialise once-daily formulations of clozapine using Elan Corporation plc's ("Elan")(NYSE: ELN ) proprietary drug delivery technologies, including its NanoC...

Replidyne and Cardiovascular Systems Sign Merger Agreement

Merger to create NASDAQ-listed medical device company focused on developing and commercializing interventional treatment systems for vascular disease Conference call scheduled for Tuesday, November 4, 2008 at 8:30 AM ET LOUISVILLE, Colo. and ST. PAUL, Minn., Nov. 4 /PRNewswire-FirstCall/ -- ...

Parion Sciences and Kainos Medicines Sign Clinical Development Agreement for Novel Dry Mouth Treatment

Kainos to Fund Up to $25 Million to Advance P-552 DURHAM, N.C., Oct. 28 /PRNewswire/ -- Parion Sciences, Inc. and Kainos Medicines, Inc. today announced that they have entered into an agreement to co-develop Parion's proprietary epithelial sodium channel blocker, P-552, for the trea...

GlaxoSmithKline and AFFiRiS Sign an Exclusive Licence and Option Agreement for Therapeutic Alzheimer's Disease Candidate Vaccines

VIENNA, Austria, October 23 /PRNewswire/ -- GlaxoSmithKline Biologicals S.A. (GSK) and AFFiRiS GmbH announced today the execution of a collaboration agreement granting GSK exclusive rights to AFFiRiS's Alzheimer's disease vaccine programmes, aimed at treating Alzheimer's by targeting beta-amyl...

Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program

SAN DIEGO, Oct. 7 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) and AnGes MG, Inc., have signed a non-binding Letter of Intent indicating their mutual interest to license the development and marketing rights for Vical's pandemic influenza DNA vaccines in Japan to AnGes. AnGes pla...

Fufeng Announces 2008 Interim Results With Strong Sign of Recovery

Turnover Increased by 45.7% Profit Attributable to Shareholders Increased Significantly by 161.7% HONG KONG, Aug. 14 /Xinhua-PRNewswire/ -- Fufeng Group Limited ("Fufeng" or "the Group"; HKEx: 546), a leading vertically integrated manufacturer of corn-based biochemical...

Cardinal Health, Prime Therapeutics Sign Primary Distribution Agreement

DUBLIN, Ohio, July 31 /PRNewswire-FirstCall/ -- Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced a three-year agreement with Prime Therapeutics, one of the nation's leading pharmacy benefit managers, to serve a...

Virtual world is sign of future for scientists, engineers

WEST LAFAYETTE, Ind. - Purdue University is operating a virtual environment that enables scientists and engineers to interpret raw data collected with powerful instruments called dynamic atomic force microscopes. The online tools, believed to be the first of their kind for the instruments, repr...

Cellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology

BIOCITECH, France, July 3 /PRNewswire-FirstCall/ -- Cellectis SA today announced the signature of an agreement with Regeneron Pharmaceuticals, Inc. over the use of Cellectis' patents covering certain uses of homologous recombination for the generation of innovative human therapies, including t...

BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use

BioTime, Inc., (OTCBB:BTIM) and BioTime’s wholly-owned subsidiary Embryome Sciences, Inc., have signed a manufacturing and distribution agreement with International Stem Cell Corporation (OTCBB:ISCO) through its wholly-owned subsidiary Lifeline Cell Technology (Lifeline) to jointly produce ...